Initiation of DNA interstrand cross-link repair in mammalian cells

Erica M. Hlavin, Michael B. Smeaton, Paul S. Miller

Research output: Contribution to journalArticle

Abstract

Interstrand cross-links (ICLs) are among the most cytotoxic DNA lesions to cells because they prevent the two DNA strands from separating, thereby precluding replication and transcription. Even though chemotherapeutic cross-linking agents are well established in clinical use, and numerous repair proteins have been implicated in the initial events of mammalian ICL repair, the precise mechanistic details of these events remain to be elucidated. This review will summarize our current understanding of how ICL repair is initiated with an emphasis on the context (replicating, transcribed or quiescent DNA) in which the ICL is recognized, and how the chemical and physical properties of ICLs influence repair. Although most studies have focused on replication-dependent repair because of the relation to highly replicative tumor cells, replication-independent ICL repair is likely to be important in the circumvention of cross-link cytotoxicity in nondividing, terminally differentiated cells that may be challenged with exogenous or endogenous sources of ICLs. Consequently, the ICL repair pathway that should be considered "dominant" appears to depend on the cell type and the DNA context in which the ICL is encountered. The ability to define and inhibit distinct pathways of ICL repair in different cell cycle phases may help in developing methods that increase cytotoxicity to cancer cells while reducing side-effects in nondividing normal cells. This may also lead to a better understanding of pathways that protect against malignancy and aging.

Original languageEnglish (US)
Pages (from-to)604-624
Number of pages21
JournalEnvironmental and Molecular Mutagenesis
Volume51
Issue number6
DOIs
StatePublished - Jul 2010

Fingerprint

DNA
Neoplasms
Cell Cycle
Proteins

Keywords

  • Cross-link structure
  • Cross-link unhooking
  • Global genome repair
  • Replication-coupled repair
  • Transcription-coupled repair

ASJC Scopus subject areas

  • Health, Toxicology and Mutagenesis
  • Epidemiology
  • Genetics(clinical)

Cite this

Initiation of DNA interstrand cross-link repair in mammalian cells. / Hlavin, Erica M.; Smeaton, Michael B.; Miller, Paul S.

In: Environmental and Molecular Mutagenesis, Vol. 51, No. 6, 07.2010, p. 604-624.

Research output: Contribution to journalArticle

Hlavin, Erica M. ; Smeaton, Michael B. ; Miller, Paul S. / Initiation of DNA interstrand cross-link repair in mammalian cells. In: Environmental and Molecular Mutagenesis. 2010 ; Vol. 51, No. 6. pp. 604-624.
@article{20a23c3ff4e241b8a460ea4163b96377,
title = "Initiation of DNA interstrand cross-link repair in mammalian cells",
abstract = "Interstrand cross-links (ICLs) are among the most cytotoxic DNA lesions to cells because they prevent the two DNA strands from separating, thereby precluding replication and transcription. Even though chemotherapeutic cross-linking agents are well established in clinical use, and numerous repair proteins have been implicated in the initial events of mammalian ICL repair, the precise mechanistic details of these events remain to be elucidated. This review will summarize our current understanding of how ICL repair is initiated with an emphasis on the context (replicating, transcribed or quiescent DNA) in which the ICL is recognized, and how the chemical and physical properties of ICLs influence repair. Although most studies have focused on replication-dependent repair because of the relation to highly replicative tumor cells, replication-independent ICL repair is likely to be important in the circumvention of cross-link cytotoxicity in nondividing, terminally differentiated cells that may be challenged with exogenous or endogenous sources of ICLs. Consequently, the ICL repair pathway that should be considered {"}dominant{"} appears to depend on the cell type and the DNA context in which the ICL is encountered. The ability to define and inhibit distinct pathways of ICL repair in different cell cycle phases may help in developing methods that increase cytotoxicity to cancer cells while reducing side-effects in nondividing normal cells. This may also lead to a better understanding of pathways that protect against malignancy and aging.",
keywords = "Cross-link structure, Cross-link unhooking, Global genome repair, Replication-coupled repair, Transcription-coupled repair",
author = "Hlavin, {Erica M.} and Smeaton, {Michael B.} and Miller, {Paul S.}",
year = "2010",
month = "7",
doi = "10.1002/em.20559",
language = "English (US)",
volume = "51",
pages = "604--624",
journal = "Environmental and Molecular Mutagenesis",
issn = "0893-6692",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Initiation of DNA interstrand cross-link repair in mammalian cells

AU - Hlavin, Erica M.

AU - Smeaton, Michael B.

AU - Miller, Paul S.

PY - 2010/7

Y1 - 2010/7

N2 - Interstrand cross-links (ICLs) are among the most cytotoxic DNA lesions to cells because they prevent the two DNA strands from separating, thereby precluding replication and transcription. Even though chemotherapeutic cross-linking agents are well established in clinical use, and numerous repair proteins have been implicated in the initial events of mammalian ICL repair, the precise mechanistic details of these events remain to be elucidated. This review will summarize our current understanding of how ICL repair is initiated with an emphasis on the context (replicating, transcribed or quiescent DNA) in which the ICL is recognized, and how the chemical and physical properties of ICLs influence repair. Although most studies have focused on replication-dependent repair because of the relation to highly replicative tumor cells, replication-independent ICL repair is likely to be important in the circumvention of cross-link cytotoxicity in nondividing, terminally differentiated cells that may be challenged with exogenous or endogenous sources of ICLs. Consequently, the ICL repair pathway that should be considered "dominant" appears to depend on the cell type and the DNA context in which the ICL is encountered. The ability to define and inhibit distinct pathways of ICL repair in different cell cycle phases may help in developing methods that increase cytotoxicity to cancer cells while reducing side-effects in nondividing normal cells. This may also lead to a better understanding of pathways that protect against malignancy and aging.

AB - Interstrand cross-links (ICLs) are among the most cytotoxic DNA lesions to cells because they prevent the two DNA strands from separating, thereby precluding replication and transcription. Even though chemotherapeutic cross-linking agents are well established in clinical use, and numerous repair proteins have been implicated in the initial events of mammalian ICL repair, the precise mechanistic details of these events remain to be elucidated. This review will summarize our current understanding of how ICL repair is initiated with an emphasis on the context (replicating, transcribed or quiescent DNA) in which the ICL is recognized, and how the chemical and physical properties of ICLs influence repair. Although most studies have focused on replication-dependent repair because of the relation to highly replicative tumor cells, replication-independent ICL repair is likely to be important in the circumvention of cross-link cytotoxicity in nondividing, terminally differentiated cells that may be challenged with exogenous or endogenous sources of ICLs. Consequently, the ICL repair pathway that should be considered "dominant" appears to depend on the cell type and the DNA context in which the ICL is encountered. The ability to define and inhibit distinct pathways of ICL repair in different cell cycle phases may help in developing methods that increase cytotoxicity to cancer cells while reducing side-effects in nondividing normal cells. This may also lead to a better understanding of pathways that protect against malignancy and aging.

KW - Cross-link structure

KW - Cross-link unhooking

KW - Global genome repair

KW - Replication-coupled repair

KW - Transcription-coupled repair

UR - http://www.scopus.com/inward/record.url?scp=77951889437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951889437&partnerID=8YFLogxK

U2 - 10.1002/em.20559

DO - 10.1002/em.20559

M3 - Article

VL - 51

SP - 604

EP - 624

JO - Environmental and Molecular Mutagenesis

JF - Environmental and Molecular Mutagenesis

SN - 0893-6692

IS - 6

ER -